$AEON Biopharma (AEON.US)$ Daewoong Pharmaceutical’s botulin...

$AEON Biopharma(AEON.US)$ Daewoong Pharmaceutical’s botulinum toxin product Nabota (U.S. name: Jeuveau) was patented in the U.S. as a neurotoxin composition for treating headaches through its U.S. partner, $AEON Biopharma, with exclusive rights until 2041.
https://www.koreabiomed.com/news/articleView.html?idxno=22014